A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)
Clinical trial NCT04742153 · UNKNOWN
Trial details
- NCT number
- NCT04742153
- Sponsor
- Shanghai Miracogen Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2023-02-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.